LIGATURE THERAPEUTICS
Ligature Therapeutics is an early-stage biotechnology company that develops small molecule โprotein degraderโ therapeutics. Ligature Therapeutics is an early-stage drug discovery company that takes a novel approach towards developing small molecules for targeted protein degradation to treat intractable diseases. Ligature Therapeutics was founded by doctors Alvin Hung, Thomas Keller, and Congbao Kang with initial investment from Lightstone Singapore, a Singapore-focused venture fund founded in 2016 by Lightstone Ventures.
LIGATURE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2020-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Status:
Active
Total Funding:
6 M USD
Current Employees Featured
Alvin Hung
Alvin Hung VP Chemistry @ Ligature Therapeutics VP Chemistry 2021-02-01
Thomas Keller
Thomas Keller Co-founder @ Ligature Therapeutics Co-founder
Congbao Kang
Congbao Kang Co-founder @ Ligature Therapeutics Co-founder
Founder
Alvin Hung
Congbao Kang
Thomas Keller
Investors List
Lightstone Ventures
Lightstone Ventures investment in Seed Round - Ligature Therapeutics
Seeds Capital
Seeds Capital investment in Seed Round - Ligature Therapeutics